A phase II prospective open-label escalating dose trial of recombinant interleukin-11 in mild von Willebrand disease.

Saved in:
Bibliographic Details
Title: A phase II prospective open-label escalating dose trial of recombinant interleukin-11 in mild von Willebrand disease.
Authors: RAGNI, M. V.1,2 ragni@dom.pitt.edu, JANKOWITZ, R. C.1, CHAPMAN, H. L.2, MERRICKS, E. P.3, KLOOS, M. T.3, DILLOW, A. M.3, NICHOLS, T. C.3
Source: Haemophilia. Sep2008, Vol. 14 Issue 5, p968-977. 10p. 1 Black and White Photograph, 1 Diagram, 4 Charts, 1 Graph.
Database: Academic Search Ultimate
Description
ISSN:13518216
DOI:10.1111/j.1365-2516.2008.01827.x